IDEXX Laboratories Acquires Animana B.V., Makers of the Animana Veterinary Practice Management Software

IDEXX Laboratories Acquires Animana B.V., Makers of the Animana Veterinary Practice Management Software

HOOFDDORP, The Netherlands, Oct. 30, 2014 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX) today announced that it has acquired all outstanding shares of The Netherlands-based Animana B.V. (Animana), maker of the Animana Veterinary Practice Management Software.

Animana is an intuitive, cloud-based practice information management solution that allows veterinarians and practice managers to access patient data anytime, anywhere, simply with access to the Internet. The Animana system is capable of serving veterinary practices of all sizes—from single veterinarian practices to large, multisite practices—and practices of all types, including companion animal, equine, large animal and mobile veterinary practices.
Animana complements the IDEXX Cornerstone® and DVMAX® practice management software offerings, extending IDEXX's full diagnostic and information management solution into European and other international markets.
"As we continue to make investments to accelerate our international growth, Animana will enhance our ability to provide a fully integrated IDEXX diagnostic and information management experience to our customers," said Michael Williams, IDEXX Executive Vice President. "We will continue to collaborate with our key partners in local markets to help veterinarians provide the best standard of care for pets."
"We are pleased to have the Animana team join the IDEXX family, and we are fully committed to supporting customers who have put their trust in Animana," said Tyler Patterson, General Manager, IDEXX International Information Management. "IDEXX and Animana share a vision: to help veterinary practices run their businesses efficiently, eliminate missed charges and manage their day-to-day activities so they can concentrate on practicing medicine."
"The future for Animana is exciting and we believe that this new relationship with IDEXX is very positive news for our customers," said Bas Van Ecke, one of two founders and co-owners of Animana. Mr. Van Ecke and co-owner Sebastiaan Massizzo have joined IDEXX as key leaders in IDEXX's software organization.
Learn more about Animana Software at or contact Patrick Govart, Senior Marketing Manager, International Information Management, at [email protected] or +33-611-03-62-06.
About IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk. Headquartered in Maine, IDEXX Laboratories employs more than 6,000 people and offers products to customers in over 175 countries.
Note Regarding Forward-Looking Statements
This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on management's current expectations and beliefs, as well as a number of assumptions concerning future events. These statements are subject to risks, uncertainties, assumptions and other important factors. Readers are cautioned not to put undue reliance on such forward-looking statements because actual results may vary materially from those expressed or implied. The reports filed by the Company pursuant to United States securities laws contain discussions of these risks and uncertainties. The Company assumes no obligation to, and expressly disclaims any obligation to, update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers are advised to review the Company's filings with the United States Securities and Exchange Commission (which are available from the SEC's EDGAR database at, at various SEC reference facilities in the United States and via the Company's website at

SOURCE IDEXX Laboratories, Inc.


Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…